cvs health glp-1 receptor agonist weight management diabetes treatments MinuteClinic® Loss Program, which may include FDA approved medications Impact of the CVS GLP-1

Obesity as a multisystem disease: trends in obesity rates and obesity-related complications

Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: Prospective cohort study

Omid Mehrpour (MD, FACMT) is a senior medical toxicologist and physician-scientist with over 15 years of clinical and academic experience in emergency medicine and toxicology

Semaglutide GLP-1 (Ozempic, Wegovy) and Zepbound ( tirzepatide ) are two of the most discussed medications for weight loss, and many of our patients inquire about their long-term safety

Furthermore, it will be essential to ensure that access is equitable, clinically justified, and aligned with evidence-based guidelines to prevent widening health inequalities or encouraging inappropriate prescribing

A total of 145 participants (33.1% with type 2 diabetes) were randomly assigned to once weekly efinopegdutide 10 mg or semaglutide 1 mg following dose titration